Download Files:
GSK2983559
SKU
HY-112038A-10 mg
Category Reference compound
Tags Apoptosis, Inflammation/Immunology, RIP kinase
$120 – $1,050
Products Details
Product Description
– GSK2983559 is an orally active and potent receptor interacting protein 2 (RIP2) kinase inhibitor. GSK2983559 blocks many proinflammatory cytokine responses in vivo and in human inflammatory bowel disease explant samples[1].
Web ID
– HY-112038A
Storage Temperature
– -20°C (Powder, sealed storage, away from moisture)
Shipping
– Blue Ice
Applications
– COVID-19-immunoregulation
Molecular Formula
– C21H28CaN4O10PS2
References
– [1]Pamela A Haile, et al. Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of Inflammatory Diseases. J Med Chem. 2019 Jul 25;62(14):6482-6494.|[2]Shuwei Wu, et al. Design, synthesis, and structure-activity relationship of novel RIPK2 inhibitors. Bioorg Med Chem Lett. 2022 Sep 2;75:128968.
Molecular Weight
– 611.61
Compound Purity
– 99.24
SMILES
– CC(C)(C)S(C(C(OCCOP(O)([O-])=O)=CC1=NC=N2)=CC1=C2NC3=CC(N=CS4)=C4C=C3)(=O)=O.[H]O[H].[H]O[H].[H]O[H].[Ca+2].[1/2]
Clinical Information
– Phase 1
Research Area
– Inflammation/Immunology
Solubility
– DMF : < 1 mg/mL (ultrasonic;warming;heat to 80°C)|DMSO : < 1 mg/mL (ultrasonic;warming;heat to 80°C)|Ethanol : < 1 mg/mL (ultrasonic)|H2O : 2 mg/mL (ultrasonic)
Target
– RIP kinase
Isoform
– RIPK2
Pathway
– Apoptosis
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.